FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule


Advisory Committees

Waivers for Conflicts of Interest

The Food and Drug Administration Amendments Act of 2007 (FDAAA), enacted on September 27, 2007, added a new provision regarding financial conflicts of interest, § 712 of the Federal Food, Drug, and Cosmetic Act (FD&C Act), effective October 1, 2007. Accordingly, for advisory committee meetings after October 1, 2007, FDA is granting waivers under 18 U.S.C. § 208 and § 712 of the FD&C Act, where applicable, when the relevant waiver standards in these statutes are met.

Waivers under 21 U.S.C. § 355(n)(4) were issued before October 1, 2007.  This provision was repealed, effective October 1, 2007, by the FDA.

Psychopharmacologic Drugs Advisory Committee


February 06, 2007


Andrew Leon, Ph.D.


  • 18 U.S.C. 208 waiver (pdf)
  • 712 (c) (2) (B) waiver (pdf)
  • Acknowledgement and consent (pdf)


David Shaffer, Ph.D.


  • 18 U.S.C. 208 waiver (pdf)
  • Acknowledgement and consent (pdf)


Andrew Winokur, M.D.


  • 18 U.S.C. 208 waiver (pdf)
  • Acknowledgement and consent (pdf)

Page updated: January 22, 2008